BRITANNIA LIFE SCIENCES (L020) - Total Liabilities
Based on the latest financial reports, BRITANNIA LIFE SCIENCES (L020) has total liabilities worth €4.83 Million EUR (≈ $5.65 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore L020 cash flow conversion to assess how effectively this company generates cash.
BRITANNIA LIFE SCIENCES - Total Liabilities Trend (2022–2025)
This chart illustrates how BRITANNIA LIFE SCIENCES's total liabilities have evolved over time, based on quarterly financial data. Check BRITANNIA LIFE SCIENCES liquidity resilience to evaluate the company's liquid asset resilience ratio.
BRITANNIA LIFE SCIENCES Competitors by Total Liabilities
The table below lists competitors of BRITANNIA LIFE SCIENCES ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
WebRock Ventures AB
ST:WRV
|
Sweden | Skr775.00K |
|
Torr Metals Inc
V:TMET
|
Canada | CA$1.09 Million |
|
HUIJING HLDG.CO.LTD HD-01
F:3XU
|
Germany | €10.48 Billion |
|
Cadoux Ltd
AU:CCM
|
Australia | AU$1.38 Million |
|
Alkali Metals Limited
NSE:ALKALI
|
India | Rs415.41 Million |
|
Mathios Refractories S.A.
AT:MATHIO
|
Greece | €15.98 Million |
|
Ajooni Biotech Limited
NSE:AJOONI
|
India | Rs226.46 Million |
Liability Composition Analysis (2022–2025)
This chart breaks down BRITANNIA LIFE SCIENCES's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BRITANNIA LIFE SCIENCES market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BRITANNIA LIFE SCIENCES's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BRITANNIA LIFE SCIENCES (2022–2025)
The table below shows the annual total liabilities of BRITANNIA LIFE SCIENCES from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | €5.31 Million ≈ $6.21 Million |
-65.94% |
| 2024-03-31 | €15.59 Million ≈ $18.23 Million |
+24.87% |
| 2023-03-31 | €12.49 Million ≈ $14.60 Million |
-20.00% |
| 2022-03-31 | €15.61 Million ≈ $18.25 Million |
-- |
About BRITANNIA LIFE SCIENCES
Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. It serves cosmetics, consumer packaged and household goods, and nutraceutical industries. The company is headquartered in Toronto, Canada.